Efficacy and Safety Study of Low-Dose Ondansetron For Adjunctive Therapy In Adult Patients With Obsessive-Compulsive Disorder

Eastside Comprehensive Medical Center, LLC, New York

Columbia University Medical Center NYS Psychiatric Institute, New York

Montefiore Medical Center, Child Psychiatry Annex, The Bronx

Biobehavioral Institute, Hofstra, Great Neck

Richard H. Weisler, MD, PA, and Associates, Raleigh

Carman Research, Smyrna

Emory University, Atlanta

Compass Research, LLC, Orlando

University of South Florida, St. Petersburg

Hospital Aranda de la Parra S.A. de C.V., León

Quest Therapeutics of Avon Lake, Avon Lake

Estudios Integrales en Salud Mental, S.C., Guadalajara

Lindner Center of HOPE University of Cincinnati, Mason

The Rogers Center for Research and Training, Milwaukee

Dean Foundation, Middleton

Instituto para el Fortalecimiento de Capacidades en Salud, Tlalnepantla

Ambulatory Research Center, Dept of Psychiatry, Minneapolis

CIT Neuropsique, Monterrey

Centro par alas Adicciones y Salud Mental S.A., Monterrey

Instituto de Informacion e Investigacion en Salud Mental, A.C. (INFOSAME), Monterrey

Hospital Lomas de San Luis Internacional, San Luis Potosí City

Clinical Trials of Texas, Inc, San Antonio

Pacific Institute for Medical Research, Los Angeles

Southwestern Research, Inc., Beverly Hills

Sun Valley Research Center, Imperial

Instituto para el Fortalecimiento de Capacidades en Salud: Focus Salud Mexico S.C., Mérida

McLean Hospital, Belmont

Beacon Clinical Research, LLC, New Bedford

Comprehensive Clinical Research, Berlin

The Body Dysmorphic Disorder (BDD) Program, Providence

Grupo de Estudios Medicos y Familiares, Mexico City

Instituto Mexicano de Investigacion Clinica S.A. de C.V. (IMIC), Mexico City